A study presented at The Liver Meeting 2019 found that duodenal mucosal resurfacing -- an ablative procedure which aims to enhance the regrowth of duodenal mucosa -- was safe and effective in improving metabolic function in patients with type 2 diabetes. Using data from 75 patients, the researchers found that the median change in A1C at 24 weeks was -0.6% for patients who underwent DMR, and median change in liver magnetic resonance imaging-proton density fat fraction was -5.4%, compared with -0.3% and -2.4% for those who had a sham procedure.
DMR procedure shows metabolic effects in type 2 diabetes
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.